Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Romeo who wrote (5536)	10/20/1998 7:35:00 AM
From: M. Alexander	Read Replies (1) of 6136

Thanks JLR, Eventually I will call. It would be nice to get the latest analysts ideas. I found that McCamant believes it to be from an overestimate of numbers for revenues from Roche and a $26 mil. one time write off for the Remune and Japanese HIV drugs in-licensing. Also at www.earningswhispers.com it is believed AGPH will fall short of 1Q99 by 80%! Anyway...That and the thing about FBDIX's manager shorting AGPH is annoying. We'll see very soon about that. And about DD, and the tracking stock. Could be R&D again... Here is another question that I may end up answering myself or ..maybe I'll hear it from Donna Nichols... what is the relationship with Roche? I haven't gotten to that yet. M Alexander

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next